Triptorelin: 2mg
Reproductive healthDescription
Triptorelin is a long-acting synthetic gnrh (gonadotropin-releasing hormone) agonist decapeptide with approximately 100 times the receptor binding potency of native gnrh. triptorelin's primary research application in the peptide community is hpg (hypothalamic-pituitary-gonadal) axis restart after suppression from exogenous testosterone (trt) or anabolic androgen use — a protocol where a single low dose (0.1mg) triggers a powerful initial lh and fsh flare response by massively stimulating pituitary gnrh receptors before the agonist-induced downregulation of those receptors occurs. this flare effect is exploited in restart protocols because an hpg-suppressed axis responds to the initial gnrh surge with a compensatory lh spike that stimulates leydig cell testosterone production. in sustained use (as in prostate cancer treatment), continuous gnrh agonism causes receptor downregulation and hormonal castration — the opposite of the restart effect. the restart protocol is a precise single-dose application. approved medically as trelstar (usa) and decapeptyl (eu) for prostate cancer, endometriosis, and precocious puberty in long-acting depot formulations. the restart application uses a very small single subcutaneous dose, not a depot preparation. post-trt restart: wait 4-6 weeks after last testosterone dose before administration. monitor lh, fsh, and total testosterone at 2 and 4 weeks post-dose to confirm axis recovery. for research and educational purposes only. consult a qualified healthcare professional.
Specifications
| Amount in Vial | 2mg |
|---|---|
| BAC Water | 2ml |
| Amount per Unit | 0.01mg per unit |
| Recommended Dose | 0.1mg (10 units) — single dose for hpg restart |
| Frequency | Single dose protocol — not for repeated use |
| Injection Type | Subcutaneous |
| Timing | Single 0.1mg (10 unit) dose for HPG axis restart. Administer 4-6 weeks after last exogenous androgen dose. Monitor LH, FSH, total testosterone at 2 and 4 weeks post-administration. Not for chronic or repeated dosing — sustained agonism causes receptor downregulation and hormonal suppression rather than stimulation. The full 2mg vial provides 20 single restart doses — store remaining reconstituted solution at 4C and use within 30 days. |
Dose Calculator
Based on 0.01mg per unit (100-unit insulin syringe)
Quick Reference
Reconstitution
Vial size: 2mg
Add BAC water: 2ml
Concentration: 0.01mg per unit
For research and educational use only.
This page provides research dosing information only. Not intended as medical advice. Consult a qualified professional before any use.